BiotechTube
Home/Eleva/Björn Cochlovius, Ph.D., Assoc. Prof.
BC

Björn Cochlovius, Ph.D., Assoc. Prof.

Chief Executive Officer & Managing Director

Eleva

Therapeutic Areas

Complement DisordersNephrologyOphthalmologyRare Diseases

Eleva Pipeline

DrugIndicationPhase
Factor H (CPV-104)Complement DisordersPhase 1
Undisclosed ProgramComplement-driven diseases / Dry AMDPhase 1

Leadership Team at Eleva

DA
Dr. Andreas Schaaf, Ph.D.
Chief Scientific Officer & Managing Director
DS
Donato Spota, M.Sc.
Chief Financial Officer & Managing Director
DE
Dr. Erich Rajkovic, MBA
Chief Business Officer
DM
Dr. Martin Bauer, MD, FNWC
Chief Medical Officer (external)
View full Eleva profile